Lava Therapeutics
Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of cancer.
Healthtech
Funding summary
- Total raised
- €70.1M
- Funding rounds
- 1
Investors in Lava Therapeutics
Investors on record for Lava Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Lava Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors